Pharmafile Logo
Pharmafocus logo
Advanced Search

Government to harness NHS patient data for research use

August 2, 2012
Sales and Marketing NHS, R&D, UK, david cameron, innovation, real world data

The UK government will change the NHS Constitution in order to allow patients’ data to be used for research purposes. …

News
ABPI image

New UK drug pricing system will ‘stifle innovation’

August 2, 2012
Sales and Marketing ABPI, PPRS, UK government, VBP

The ABPI has attacked the UK government’s new drug pricing policy, saying it will not benefit the pharma industry. Value-Based …

News
Daiichi Sankyo UK

Daiichi Sankyo: breaking down barriers with social media

August 1, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chatter, Daiichi Sankyo, NHS, social media

Digital media is known to help create interaction and dialogue between groups and organisations, but new technology can also create …

Feature

Olympics to kick-start research ventures

August 1, 2012
Research and Development, Sales and Marketing GSK, London 2012, Olympics, research

London 2012 could provide a boost in the continuing search for personalised medicines for diabetes, heart disease and dementia as …

News

MRN posts 533% growth in first five years

August 1, 2012
Research and Development clinical trials, growth, results

From humble beginnings in 2006 with six dedicated staff members and a vision to transform clinical trial support, the Medical …

News
Press release

Lucid Communication joins forces with Luther Pendragon

August 1, 2012
Medical Communications Lucid communications, Luther Pendragon

Communciations agency Luther Pendragon has purchased PR firm Lucid Communication to help expand its US client base. The deal will …

News

Pfizer’s RA pill impresses in Phase III

August 1, 2012
Research and Development, Sales and Marketing FDA, JAK, Pfizer, RA

Pfizer’s investigational arthritis drug tofacitinib has beaten methotrexate in a head-to-head study. Tofacitinib, an oral Janus kinase (JAK) inhibitor, is …

News

Just:: Health PR promotes Laura Chambers to its senior team

July 31, 2012
Medical Communications Just:: Health PR, Laura Chambers, just health pr

Just:: Health PR has promoted Laura Chambers to the position of director. Chambers will join fellow directors Tamsin Tierney and …

Appointment

Lipitor loss continues to hit Pfizer sales

July 31, 2012
Sales and Marketing Enbrel, Lipitor, Pfizer, Prevnar, Q2

Pfizer has posted a loss in revenue for the second quarter as the firm continues to feel the impact of …

News

Dendreon slashes staff and closes facility

July 31, 2012
Manufacturing and Production, Sales and Marketing Dendreon, M&P, Provenge, prostate cancer

Cancer vaccine specialist Dendreon has said it will slash 600 jobs and close one of its three manufacturing facilities in …

News

Ariad files new blood cancer drug with the FDA

July 31, 2012
Research and Development, Sales and Marketing Ariad, CML, EMA, FDA, Glivec, blood cancer

Ariad has filed its investigational blood cancer drug ponatinib with the FDA and hopes for an accelerated review. The US …

News
Astrazeneca image

AstraZeneca launches virtual research laboratory

July 31, 2012
Medical Communications Assay Depot, AstraZeneca, R&D, virtual

AstraZeneca and partner Assay Depot have launched a virtual research laboratory aimed at helping its scientists create R&D collaborations. The …

News
tulstrup

Soren Tulstrup to lead Shire’s genetics franchise

July 31, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Shire has appointed Soren Tulstrup as its new senior vice president and franchise lead, MPS (mucopolysaccharides) for its human genetic …

Appointment

Bayer raises guidance after strong sales

July 31, 2012
Sales and Marketing Bayer, Nexavar, Q2, Xarelto, Yasmin

The Bayer Group has raised its full-year guidance for 2012 following positive results in the second quarter. This is despite …

News
fda_building

Fitch to pharma: don’t expect 2012 to be a bumper year

July 31, 2012
Sales and Marketing 2012, FDA approvals, Fitch, IMS Health, NMEs, ratings

The Fitch ratings agency has published pessimistic projections for pharma, saying that it should not expect as many US drug …

News

Leading producer of auto injectors SHL hires over 600 new employees

July 31, 2012
Manufacturing and Production auto injector, autoinjector, pen injector, shl group

In response to increased customer orders and the signing of long-term contracts, SHL has hired more than 600 new employees …

News
Press release
Merck image

Merck sees growth in second quarter

July 30, 2012
Sales and Marketing Cozaar, Merck, Q2, Singulair

Merck has posted a healthy sales increase for the second quarter, as its established drugs grew strongly. Sales increased 1% …

News

Parkinson’s specialist spins out from Merck Serono’s Swiss R&D ops

July 30, 2012
Research and Development, Sales and Marketing Merck Serono, Parkinson's, Prexton, Swiss

A company specialising in novel treatments for Parkinson’s disease is the first to be spun out of Merck Serono’s soon-to-close …

News
Bayer image

Bayer guilty of multiple Code breaches

July 30, 2012
Medical Communications, Sales and Marketing ABPI Code, Bayer, Xarelto, breach, clause

Bayer Healthcare has admitted to 12 breaches of the ABPI Code after one of its staff developed and distributed drug …

News
david-meek

Novartis’ David Meek moves to Endocyte

July 30, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Endocyte, Novartis, appointment

David Meek has been appointed to the newly created position of chief commercial officer at the biotechnology firm Endocyte. Meek …

Appointment
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026